Jimmidi, Ravikumar
Chamakuri, Srinivas http://orcid.org/0000-0002-7586-4992
Lu, Shuo
Ucisik, Melek Nihan
Chen, Peng-Jen
Bohren, Kurt M. http://orcid.org/0000-0002-3183-4118
Moghadasi, Seyed Arad
Versteeg, Leroy
Nnabuife, Christina http://orcid.org/0000-0001-9907-0508
Li, Jian-Yuan
Qin, Xuan http://orcid.org/0000-0003-3728-5911
Chen, Ying-Chu
Faver, John C.
Nyshadham, Pranavanand
Sharma, Kiran L.
Sankaran, Banumathi http://orcid.org/0000-0002-3266-8131
Judge, Allison http://orcid.org/0000-0003-4289-1748
Yu, Zhifeng
Li, Feng http://orcid.org/0000-0002-9680-4614
Pollet, Jeroen http://orcid.org/0000-0003-1420-4015
Harris, Reuben S.
Matzuk, Martin M.
Palzkill, Timothy http://orcid.org/0000-0002-5267-0001
Young, Damian W. http://orcid.org/0000-0002-1595-9658
Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (U19-AI171954)
Welch Foundation (H-Q-0042)
Cancer Prevention and Research Institute of Texas (RP160805)
Division of Cancer Prevention, National Cancer Institute (P20CA221729)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM124169-01)
Article History
Received: 28 March 2023
Accepted: 19 July 2023
First Online: 4 August 2023
Competing interests
: We patented the molecules described in this paper and their uses. Patent Title: Coronavirus Main Protease Inhibitors and Methods Using Same. International publication number WO2023004291A1. Authors: S.C., S.L., M.N.U., Y.-C.C., J.C.F., R.J., Z.Y., M.M.M., T.P., and D.W.Y. All other authors declare no competing interests.